title: Exenatide-a potential role in treatment of HNF1-alpha MODY in obese patients?
authors.forename: R
authors.initials: R
authors.lastname: Ahluwalia
authors.forename: K
authors.initials: K
authors.lastname: Perkins
authors.forename: D
authors.initials: D
authors.lastname: Ewins
authors.forename: N
authors.initials: N
authors.lastname: Goenka
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D051538:Hepatocyte Nuclear Factor 1-alpha / Q000235:genetics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D009765:Obesity / Q000150:complications*; D010375:Pedigree; D010455:Peptides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
chemical_list: D051538:Hepatocyte Nuclear Factor 1-alpha; D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000077270:Exenatide